Author

A.-M. Ferreira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:flow cytometry· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. A. Blish· 2 shared N. Q. Zhao· 2 shared C. Seiler· 1 shared E. Vendrame· 1 shared J. D. Fontenot· 1 shared L. J. Simpson· 1 shared P. M. Grant· 1 shared S. Holmes· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. A. Blish

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Treated HIV Infection Alters Phenotype But Not HIV-specific Function of Peripheral Blood Natural Killer Cells

N. Q. Zhao, A.-M. Ferreira, P. M. Grant, S. Holmes, C. A. Blish

This study examines how treated HIV infection affects NK cell phenotype and function, finding altered repertoires but no increased HIV-specificity.

bioRxiv · Apr 12, 2020Immunology

Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry

T. Ranganath, L. J. Simpson, C. Seiler, A.-M. Ferreira, E. Vendrame, N. Q. Zhao, J. D. Fontenot, S. P. Holmes, C. A. Blish

This study uses mass cytometry to analyze how daclizumab beta affects NK cell phenotypes in RMS patients, showing distinct changes in CD56bright and CD56dim subsets.

bioRxiv · Dec 5, 2019Immunology